CDCA3 and invasive breast carcinoma: Analysis of the TCGA breast dataset showed a high expression of CDCA3 in four subtypes of breast cancer, which were invasive ductal breast carcinoma, intra-ductal cribriform breast adenocarcinoma, invasive breast carcinoma, and invasive lobular breast carcinoma, with the highest expression-level fold-change of 4.05-times higher expression in invasive ductal breast carcinoma tissue (Figure 2B).